시장보고서
상품코드
1962220

마스터 환자 인덱스 소프트웨어 시장 분석 및 예측(-2035년) : 유형별, 제품 유형별, 서비스별, 기술별, 컴포넌트별, 용도별, 도입 형태별, 최종 사용자별, 기능별, 솔루션별

Master Patient Index Software Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Deployment, End User, Functionality, Solutions

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 397 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 마스터 환자 인덱스 소프트웨어 시장은 2024년 14억 4,000만 달러에서 2034년까지 42억 달러로 확대되어 CAGR 약 11.3%를 나타낼 것으로 예측됩니다. 마스터 환자 인덱스 소프트웨어 시장은 의료 제공업체 간에 일관되고 정확한 환자 데이터를 유지하도록 설계된 시스템을 포함합니다. 이러한 솔루션은 원활한 정보 교환을 가속화하고 케어 협력을 개선하고 중복 기록을 줄입니다. 주요 시장 성장 촉진요인은 통합 의료 시스템에 대한 수요 증가와 규제 준수를 포함합니다. 시장은 상호 운용성과 데이터 보안의 진보를 보이며 환자 중심의 케어와 업무 효율에 대한 중시가 높아지고 있음을 반영합니다.

마스터 환자 인덱스 소프트웨어 시장은 의료 시스템에서 정확한 환자 데이터 관리와 상호 운용성에 대한 필요성 증가를 배경으로 현저한 성장을 이루고 있습니다. 소프트웨어 부문이 가장 높은 성장률을 보이고 있으며 클라우드 기반 솔루션은 확장성과 기존 의료 IT 인프라 간의 통합의 용이성으로 인해 주도적인 지위를 차지합니다. 이러한 솔루션은 실시간 데이터 공유를 가능하게 하고 환자 관리의 협력을 강화합니다. 이에 따라 On-Premise 도입 부문이 중요한 위치를 차지하고 있어 데이터 보안과 환자 정보 관리의 제어를 우선하는 의료기관에 있어서 여전히 중요한 선택이 되고 있습니다. 소프트웨어 분야 내에서 환자 식별 관리 솔루션은 주목을 받고 있으며 데이터의 정확성을 보장하고 중복을 줄입니다. 상호 운용성 솔루션은 규제 요구 사항과 의료 네트워크 간의 원활한 데이터 교환의 필요성으로 인해 강한 성장 가능성을 보여줍니다. 환자 데이터 관리에서 AI 및 머신러닝 기술의 채택 확대는 시장의 추가 성장을 지원합니다. 이러한 기술은 데이터의 정확성을 높이고 비즈니스 효율성을 높이고 의사결정 프로세스를 개선하여 이해관계자에게 수익성 있는 기회를 제공합니다.

시장 세분화
유형 서비스형 소프트웨어(SaaS), On-Premise, 클라우드 기반, 하이브리드
제품 독립형 소프트웨어, 통합 소프트웨어 솔루션
서비스 컨설팅 서비스, 배포 서비스, 지원 및 유지보수 서비스, 훈련 및 교육
기술 블록체인, 인공지능, 머신러닝, 데이터 분석, 상호 운용성 솔루션
구성요소 소프트웨어, 하드웨어
용도 환자 식별, 데이터 통합, 기록 관리, 데이터 조정
도입 형태 클라우드, On-Premise, 하이브리드
최종 사용자 병원, 진료소, 외래 진료 센터, 장기 요양 시설
기능 데이터 매칭, 데이터 클렌징, 데이터 표준화, 중복 레코드 관리
솔루션 신원 관리, 데이터 거버넌스, 환자 데이터 보안

마스터 환자 인덱스 소프트웨어 시장은 시장 점유율, 가격 전략, 제품 혁신의 역동적인 상호 작용을 특징으로 합니다. 각 회사는 경쟁력 있는 가격 설정으로 점유율 확대를 도모함과 동시에 신제품 투입으로 제품 포트폴리오를 강화하고 있습니다. 의료 제공업체에게 매우 중요한 상호 운용성과 고급 데이터 관리 기능에 중점을 둡니다. 조직이 환자 데이터의 정확성과 통합성을 향상시키기 위해 기존 시스템과의 원활한 연계를 실현하는 고급 소프트웨어 솔루션에 대한 투자가 진행되고 있습니다. 경쟁 측면에서 주요 기업이 기술적 우위를 추구하는 동안 시장은 치열한 경쟁 상태에 있습니다. 업계 기준과의 비교 평가를 실시하면서, 각사는 전략적 제휴나 인수를 활용해 자사 제품의 강화를 도모하고 있습니다. 특히 북미와 유럽에서 규제의 영향은 크며 시장 역학과 컴플라이언스 기준을 형성하고 있습니다. 시장 동향은 효율적인 의료 데이터 관리에 대한 수요 증가와 환자 데이터 보안의 중요성 증가에 따라 달라집니다. 이러한 요인은 강력한 마스터 환자 인덱스 소프트웨어 솔루션의 필요성을 강력하게 시사합니다.

주요 동향과 촉진요인:

마스터 환자 인덱스 소프트웨어 시장은 의료시설에서 효율적인 환자 데이터 관리의 필요성이 증가함에 따라 견조한 성장을 이루고 있습니다. 주요 동향으로 인공지능(AI)과 머신러닝 기술의 통합을 들 수 있어 데이터 정밀도가 향상되고 중복 기록이 삭감됨으로써 환자 케어의 성과 개선으로 이어지고 있습니다. 또한 의료기관이 환자 관리 최적화를 도모하기 위해 원활한 데이터 교환을 요구하는 가운데 의료 시스템 간의 상호 운용성에 대한 수요 증가도 시장 확대를 촉진하고 있습니다. 또 다른 중요한 동향은 확장성과 비용 효과를 제공하는 클라우드 기반 솔루션으로의 전환입니다. 이러한 전환은 여러 기지 간에 환자 정보에 쉽게 액세스할 수 있게 하여 공동 진료 노력을 강화합니다. 또한 환자 데이터의 프라이버시와 보안에 중점을 둔 규제 요건은 엄격한 기준을 준수하는 고급 MPI 솔루션의 채택을 의료 제공업체에게 촉구합니다. 전자건강기록(EHR)의 보급 확대도 데이터 무결성과 케어의 연속성을 확보하는데 중요한 역할을 하는 견고한 MPI 시스템 수요를 더욱 뒷받침하고 있습니다. 의료 인프라의 현대화가 진행되고 있는 신흥 시장에는 많은 기회가 존재하고, 혁신적이고 적응성이 높은 MPI 솔루션을 제공하는 기업에게 유망한 전망이 열리고 있습니다. 의료 분야가 계속 진화하는 동안, 마스터 환자 인덱스 소프트웨어 시장은 기술 진보와 환자 데이터 관리 강화의 필요성으로 인해 지속적인 성장이 예상됩니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

  • 거시경제 분석
  • 시장 동향
  • 시장 성장 촉진요인
  • 시장 기회
  • 시장 성장 억제요인
  • CAGR : 성장 분석
  • 영향 분석
  • 신흥 시장
  • 기술 로드맵
  • 전략적 프레임워크

제4장 부문 분석

  • 시장 규모 및 예측 : 유형별
    • 서비스형 소프트웨어(SaaS)
    • On-Premise
    • 클라우드 기반
    • 하이브리드
  • 시장 규모 및 예측 : 제품별
    • 독립형 소프트웨어
    • 통합 소프트웨어 솔루션
  • 시장 규모 및 예측 : 서비스별
    • 컨설팅 서비스
    • 도입 서비스
    • 지원 및 유지보수 서비스
    • 훈련 및 교육
  • 시장 규모 및 예측 : 기술별
    • 블록체인
    • 인공지능
    • 머신러닝
    • 데이터 분석
    • 상호 운용성 솔루션
  • 시장 규모 및 예측 : 컴포넌트별
    • 소프트웨어
    • 하드웨어
  • 시장 규모 및 예측 : 용도별
    • 환자 식별
    • 데이터 통합
    • 기록 관리
    • 데이터 조정
  • 시장 규모 및 예측 : 전개별
    • 클라우드
    • On-Premise
    • 하이브리드
  • 시장 규모 및 예측 : 최종 사용자별
    • 병원
    • 진료소
    • 외래 진료 센터
    • 장기 요양 시설
  • 시장 규모 및 예측 : 기능별
    • 데이터 매칭
    • 데이터 클렌징
    • 데이터 표준화
    • 중복 레코드 관리
  • 시장 규모 및 예측 : 솔루션별
    • 신원 관리
    • 데이터 거버넌스
    • 환자 데이터 보안

제5장 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카
  • 아시아태평양
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주
    • 대만
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 사하라 이남 아프리카
    • 기타 중동 및 아프리카

제6장 시장 전략

  • 수요 및 공급의 갭 분석
  • 무역 및 물류상의 제약
  • 가격, 비용, 마진의 동향
  • 시장 침투
  • 소비자 분석
  • 규제 개요

제7장 경쟁 정보

  • 시장 포지셔닝
  • 시장 점유율
  • 경쟁 벤치마킹
  • 주요 기업의 전략

제8장 기업 프로파일

  • Next Gate
  • Quadra Med
  • Cure MD
  • Medsphere Systems
  • e Clinical Works
  • Allscripts Healthcare Solutions
  • Health Catalyst
  • Orion Health
  • Verato
  • Cognizant
  • Epic Systems
  • Cerner
  • Intersystems
  • Health EC
  • Well Sky
  • Greenway Health
  • Meditech
  • Care Cloud
  • Advanced MD
  • Picis

제9장 당사에 대해서

JHS 26.03.25

Master Patient Index Software Market is anticipated to expand from $1.44 billion in 2024 to $4.2 billion by 2034, growing at a CAGR of approximately 11.3%. The Master Patient Index Software Market encompasses systems designed to maintain consistent and accurate patient data across healthcare providers. These solutions facilitate seamless information exchange, improving care coordination and reducing duplicate records. Key drivers include the rising demand for integrated healthcare systems and regulatory compliance. The market is witnessing advancements in interoperability and data security, reflecting a growing emphasis on patient-centric care and operational efficiency.

The Master Patient Index Software Market is experiencing notable growth, propelled by the increasing need for accurate patient data management and interoperability in healthcare systems. The software segment is the top performer, with cloud-based solutions leading due to their scalability and ease of integration with existing healthcare IT infrastructures. These solutions facilitate real-time data sharing and enhance patient care coordination. Following closely is the on-premise deployment segment, which remains significant for healthcare providers prioritizing data security and control over patient information. Within the software segment, patient identity management solutions are gaining traction, ensuring data accuracy and reducing duplication. Interoperability solutions also show strong potential, driven by regulatory requirements and the need for seamless data exchange across healthcare networks. The rising adoption of AI and machine learning technologies in patient data management is further supporting market expansion. These technologies enhance data accuracy, streamline operations, and improve decision-making processes, offering lucrative opportunities for stakeholders.

Market Segmentation
TypeSoftware-as-a-Service (SaaS), On-Premise, Cloud-Based, Hybrid
ProductStandalone Software, Integrated Software Solutions
ServicesConsulting Services, Implementation Services, Support and Maintenance Services, Training and Education
TechnologyBlockchain, Artificial Intelligence, Machine Learning, Data Analytics, Interoperability Solutions
ComponentSoftware, Hardware
ApplicationPatient Identification, Data Integration, Record Management, Data Reconciliation
DeploymentCloud, On-Premise, Hybrid
End UserHospitals, Clinics, Ambulatory Care Centers, Long-term Care Facilities
FunctionalityData Matching, Data Cleansing, Data Standardization, Duplicate Record Management
SolutionsIdentity Management, Data Governance, Patient Data Security

The Master Patient Index Software Market is characterized by a dynamic interplay of market share, pricing strategies, and product innovation. Companies are focusing on competitive pricing to capture a larger share, while new product launches are enhancing their portfolios. The emphasis is on interoperability and advanced data management capabilities, which are crucial for healthcare providers. As organizations strive to improve patient data accuracy and integration, they are investing in sophisticated software solutions that offer seamless integration with existing systems. In terms of competition, the market is highly competitive with key players striving for technological superiority. Benchmarking against industry standards, companies are leveraging strategic partnerships and acquisitions to enhance their offerings. Regulatory influences, particularly in North America and Europe, are significant, shaping market dynamics and compliance standards. The market's trajectory is influenced by the increasing demand for efficient healthcare data management and the growing importance of patient data security. These factors underscore the critical need for robust Master Patient Index Software solutions.

Tariff Impact:

The Master Patient Index Software Market is increasingly influenced by global tariffs and geopolitical tensions, particularly among Japan, South Korea, China, and Taiwan. Japan and South Korea, heavily dependent on imported software components, are navigating tariff-induced cost pressures by enhancing domestic capabilities and fostering regional partnerships. China's strategic pivot toward self-reliance in technology underscores its resilience amid export restrictions, while Taiwan's pivotal role in software and semiconductor supply chains is tempered by geopolitical vulnerabilities. Globally, the market benefits from a heightened focus on healthcare digitization, yet faces challenges from supply chain disruptions and energy price volatility, exacerbated by Middle East conflicts. By 2035, the market is projected to thrive through innovation, strategic alliances, and robust supply chain diversification, ensuring resilience against geopolitical and economic headwinds.

Geographical Overview:

The Master Patient Index (MPI) Software Market is witnessing substantial growth across various regions, each exhibiting unique dynamics. North America remains at the forefront, driven by advanced healthcare IT infrastructure and a strong focus on patient data management. The region's robust regulatory framework further accelerates the adoption of MPI solutions. Europe follows, with increasing investments in healthcare digitization and a growing emphasis on interoperability of patient data systems. The Asia Pacific region is experiencing rapid expansion, fueled by government initiatives to enhance healthcare IT and the rising demand for efficient patient management systems. Emerging economies like India and China are making significant strides, contributing to the region's growth. Latin America and the Middle East & Africa are emerging as promising markets. In Latin America, the modernization of healthcare systems is driving MPI adoption, while the Middle East & Africa are recognizing the potential of MPI software in improving healthcare outcomes and operational efficiency.

Key Trends and Drivers:

The Master Patient Index Software Market is experiencing robust growth, driven by the increasing need for efficient patient data management in healthcare facilities. A key trend is the integration of artificial intelligence and machine learning technologies, which enhances data accuracy and reduces duplicate records, leading to improved patient care outcomes. The rising demand for interoperability among healthcare systems also propels market expansion, as institutions seek seamless data exchange to optimize patient management. Another significant trend is the shift towards cloud-based solutions, offering scalability and cost-effectiveness. This transition facilitates easier access to patient information across multiple locations, enhancing collaborative care efforts. Additionally, regulatory mandates emphasizing patient data privacy and security are pushing healthcare providers to adopt advanced MPI solutions that comply with stringent standards. The growing prevalence of electronic health records further fuels the demand for robust MPI systems, as they play a critical role in ensuring data integrity and continuity of care. Opportunities abound in emerging markets where healthcare infrastructure modernization is underway, presenting lucrative prospects for companies offering innovative and adaptable MPI solutions. As the healthcare sector continues to evolve, the Master Patient Index Software Market is poised for sustained growth, driven by technological advancements and the imperative for enhanced patient data management.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Software-as-a-Service (SaaS)
    • 4.1.2 On-Premise
    • 4.1.3 Cloud-Based
    • 4.1.4 Hybrid
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Standalone Software
    • 4.2.2 Integrated Software Solutions
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting Services
    • 4.3.2 Implementation Services
    • 4.3.3 Support and Maintenance Services
    • 4.3.4 Training and Education
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Blockchain
    • 4.4.2 Artificial Intelligence
    • 4.4.3 Machine Learning
    • 4.4.4 Data Analytics
    • 4.4.5 Interoperability Solutions
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Patient Identification
    • 4.6.2 Data Integration
    • 4.6.3 Record Management
    • 4.6.4 Data Reconciliation
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 Cloud
    • 4.7.2 On-Premise
    • 4.7.3 Hybrid
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Hospitals
    • 4.8.2 Clinics
    • 4.8.3 Ambulatory Care Centers
    • 4.8.4 Long-term Care Facilities
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Data Matching
    • 4.9.2 Data Cleansing
    • 4.9.3 Data Standardization
    • 4.9.4 Duplicate Record Management
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Identity Management
    • 4.10.2 Data Governance
    • 4.10.3 Patient Data Security

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Deployment
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Deployment
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Deployment
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Deployment
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Deployment
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Deployment
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Deployment
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Deployment
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Deployment
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Deployment
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Deployment
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Deployment
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 Deployment
      • 5.4.7.8 End User
      • 5.4.7.9 Functionality
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Deployment
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Deployment
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Deployment
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Deployment
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Deployment
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 Deployment
      • 5.5.6.8 End User
      • 5.5.6.9 Functionality
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Deployment
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Deployment
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Deployment
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Deployment
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 Deployment
      • 5.6.5.8 End User
      • 5.6.5.9 Functionality
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Next Gate
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Quadra Med
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Cure MD
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Medsphere Systems
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 e Clinical Works
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Allscripts Healthcare Solutions
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Health Catalyst
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Orion Health
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Verato
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Cognizant
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Epic Systems
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Cerner
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Intersystems
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Health EC
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Well Sky
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Greenway Health
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Meditech
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Care Cloud
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Advanced MD
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Picis
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제